Research ArticleTUMOR MICROENVIRONMENT

Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity

See allHide authors and affiliations

Science Immunology  21 Jun 2019:
Vol. 4, Issue 36, eaaw2004
DOI: 10.1126/sciimmunol.aaw2004

Article Information

vol. 4 no. 36

PubMed: 
Published By: 
History: 
  • Received November 27, 2018
  • Accepted April 24, 2019
  • .

Author Information

  1. Annelise G. Snyder1,
  2. Nicholas W. Hubbard1,
  3. Michelle N. Messmer1,
  4. Sigal B. Kofman1,
  5. Cassidy E. Hagan1,
  6. Susana L. Orozco1,2,
  7. Kristy Chiang2,
  8. Brian P. Daniels3,
  9. David Baker4 and
  10. Andrew Oberst1,*
  1. 1Department of Immunology, University of Washington, Seattle, WA 98109, USA.
  2. 2Molecular and Cellular Biology Program, University of Washington, Seattle, WA 98109, USA.
  3. 3Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA.
  4. 4Institute for Protein Design, University of Washington, Seattle, WA 98109, USA.
  1. *Corresponding author. Email: oberst{at}uw.edu

Altmetric

Article usage

Article usage: June 2019 to October 2020

AbstractFullPdf
Jun 2019316181143581
Jul 201968542601908
Aug 20191292176101
Sep 201959716294
Oct 2019514145109
Nov 20194579171
Dec 20195997054
Jan 202032512362
Feb 20202337248
Mar 20202585936
Apr 20202598753
May 20203217542
Jun 202012912150
Jul 20203310125
Aug 2020829689
Sep 202017259102
Oct 202010236116

Stay Connected to Science Immunology

Navigate This Article